Načítá se...

Metformin and metabolic diseases: a focus on hepatic aspects

Metformin has been widely used as a first-line anti-diabetic medicine for the treatment of type 2 diabetes (T2D). As a drug that primarily targets the liver, metformin suppresses hepatic glucose production (HGP), serving as the main mechanism by which metformin improves hyperglycemia of T2D. Biochem...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Med
Hlavní autoři: Zheng, Juan, Woo, Shih-Lung, Hu, Xiang, Botchlett, Rachel, Chen, Lulu, Huo, Yuqing, Wu, Chaodong
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4567274/
https://ncbi.nlm.nih.gov/pubmed/25676019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11684-015-0384-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!